合成肽 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-01. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
=== International Units === Another older unit of vitamin A activity is the international unit (IU). Like retinol equivalent, the international unit does not take into account carotenoid variable absorption and conversion to vitamin A by humans, as well as the more modern retinol activity equivalent. Food and supplement labels still generally use IU, but IU can be converted to the more useful retinol activity equivalent as follows:
=== Surgical removal === Thymectomy is the surgical removal of the thymus. The usual reason for removal is to gain access to the heart for surgery to correct congenital heart defects in the neonatal period. In neonates the relative size of the thymus obstructs surgical access to the heart and its surrounding vessels. Other indications for thymectomy include the removal of thymomas and the treatment of myasthenia gravis. Removal of the thymus in infancy often results in a fatal immunodeficiency because functional T cells have not developed. In older children and adults, who have a functioning lymphatic system with mature T cells also situated in other lymphoid organs, the effect is reduced, but includes failure to mount immune responses against new antigens, an increase in cancers, and an increase in all-cause mortality.
Bantu tribes were observed to be upholding what was described as Jewish law, including circumcision, in the 16th century. Circumcision and elements of Jewish dietary restrictions are still found among Bantu tribes.
=== Mechanical refrigeration === In the latter half of the 20th century, mechanical refrigeration began to replace ice-based systems. Soon after, mechanical refrigeration units replaced the armies of personnel required to re-ice the cars. The sliding plug door was experimentally introduced by P.F.E. (Pacific Fruit Express) in April 1947, when one of their R-40-10 series cars, #42626, was equipped with it. P.F.E.'s R-40-26 series reefers, designed in 1949 and built in 1951, were the first production series cars to be so equipped. In addition, the Santa Fe Railroad first used plug doors on their SFRD RR-47 series cars, which were also built in 1951. This type of door provided a larger six-foot opening to facilitate loading and unloading cars. These tight-fitting doors were better insulated and could maintain an even temperature inside the car. By the mid-1970s, the few remaining ice bunker cars were relegated to "top-ice" service, where crushed ice was applied atop the commodity.
Sources: en.wikipedia.org
== Recent writing == Recent articles about insulin coma treatment have attempted to explain why it was given such uncritical acceptance. In the US, Deborah Doroshow wrote that insulin coma therapy secured its foothold in psychiatry not because of scientific evidence or knowledge of any mechanism of therapeutic action, but due to the impressions it made on the minds of the medical practitioners within the local world in which it was administered and the dramatic recoveries observed in some patients. Today, she writes, those who were involved are often ashamed, recalling it as unscientific and inhumane. Administering insulin coma therapy made psychiatry seem a more legitimate medical field. Harold Bourne, who questioned the treatment at the time, said: "It meant that psychiatrists had something to do. It made them feel like real doctors instead of just institutional attendants". One retired psychiatrist who was interviewed by Doroshow "described being won over because his patients were so sick and alternative treatments did not exist". Doroshow argues that "psychiatrists used complications to exert their practical and intellectual expertise in a hospital setting" and that collective risk-taking established "especially tight bonds among unit staff members". She finds it ironic that psychiatrists "who were willing to take large therapeutic risks were extremely careful in their handling of adverse effects".
In Ireland, the potato was introduced at the end of the 16th century and quickly became the main staple food until the end of the 19th century. Among the peasants, it appears at every meal and in one form, the simplest possible, boiled in water. The tubers, with their skins, are cooked in a cauldron, the only utensil necessary for their preparation, in a bottom of water. After cooking, the contents of the cauldron are poured into a shallow wicker basket, called a skeehogue, which allows for easy draining, and the whole family, sitting around the basket in front of the fireplace, serves itself with its hands, without fork or knife. In more affluent homes, where people eat at the table, another characteristic utensil is used: a trivet in the form of a fairly high ring (dish ring). Often made of silver and richly decorated, its function was to protect the tabletop from the heat. In 1740, a shortage of potatoes led to a famine in the country – although on a smaller scale than the one that hit Europe – in Ireland in 1845, causing nearly a million deaths and several million refugees and emigrants.
=== Starvation === Starvation is a rare cause of ketoacidosis, usually instead causing physiologic ketosis without ketoacidosis. Ketoacidosis from starvation most commonly occurs in the setting of an additional metabolic stressor such as pregnancy, lactation, or acute illness.
Faculty member Isabelle Rapin has been described as a "founding mother of autism" and popularized the term "autism spectrum disorder". In 2019, researchers at Einstein mapped the entire nervous system of Caenorhabditis elegans, a classic model organism. Other work includes the discovery of the Tc1/mariner transposon superfamily and the invention of single molecule mRNA fluorescent in situ hybridization.
Retinyl acetate (also called vitamin A acetate or all‑trans‑retinol acetate) is a synthetic, fat‑soluble acetate ester of retinol often used to supply vitamin A in food fortification, dietary supplements, and topical cosmetic products. Because the acetyl group protects the alcohol functionality, the compound is markedly more stable to heat, oxygen and light than free retinol, yet is rapidly hydrolyzed in the human intestine to active retinol after ingestion. Commercially, retinyl acetate is the second most common retinyl ester after retinyl palmitate.
Sources: en.wikipedia.org
A month after Thomson's announcement of the corpuscle, he found that he could reliably deflect the rays by an electric field if he evacuated the discharge tube to a very low pressure. By comparing the deflection of a beam of cathode rays by electric and magnetic fields he obtained more robust measurements of the mass-to-charge ratio that confirmed his previous estimates. This became the classic means of measuring the charge-to-mass ratio of the electron. Later in 1899 he measured the charge of the electron to be of 6.8×10−10 esu. Thomson believed that the corpuscles emerged from the atoms of the trace gas inside his cathode-ray tubes. He thus concluded that atoms were divisible, and that the corpuscles were their building blocks. In 1904, Thomson suggested a model of the atom, hypothesizing that it was a sphere of positive matter within which electrostatic forces determined the positioning of the corpuscles. To explain the overall neutral charge of the atom, he proposed that the corpuscles were distributed in a uniform sea of positive charge. In this "plum pudding model", the electrons were seen as embedded in the positive charge like raisins in a plum pudding (although in Thomson's model they were not stationary, but orbiting rapidly). Thomson made the discovery around the same time that Walter Kaufmann and Emil Wiechert discovered the correct mass to charge ratio of these cathode rays (electrons). The name electron was adopted for these particles by the scientific community, mainly due to the advocation by George Francis FitzGerald, Joseph Larmor, and Hendrik Lorentz.
== Side effects == The most common side effects of tizanidine (>10%) include somnolence, dry mouth, asthenia (including weakness, fatigue, and/or tiredness), dizziness, hypotension, and bradycardia. At doses of 8 to 16 mg, the rates of these side effects were 78–92% for somnolence, 76–88% for dry mouth, 67–78% for asthenia, 22–45% for dizziness, 16–33% for hypotension, and 2–10% for bradycardia. Additional side effects of tizanidine may include drowsiness, nervousness, confusion, hallucinations, strange dreams, depression, vomiting, constipation, diarrhea, stomach pain, heartburn, increased muscle spasms, back pain, rash, sweating, and tingling sensations in the arms, legs, hands, and feet. Tizanidine can cause withdrawal symptoms upon abrupt discontinuation and should be gradually tapered to avoid and minimize such symptoms. Withdrawal symptoms include rebound hypertension, tachycardia, hypertonia, tremor, and anxiety.
In β+ decay, or positron emission, the weak interaction converts an atomic nucleus into a nucleus with atomic number decreased by one, while emitting a positron (e+) and an electron neutrino (νe). β+ decay generally occurs in proton-rich nuclei. The generic equation is:
A few locals, most notably Arkansas Gazette columnist John Brummett, also objected to the staging of a violent picture at their State Capitol, but the venue did close for filming during the second weekend of September. In a bizarre coincidence, one of its own Magnolia trees burned down during the staging of the helicopter crash. McCuen ordered that the hole be covered to conceal the mishap before it reopened to the public. Principal photography belatedly ended on September 26, 1990. However, more reshoots had to be staged in early 1991 in Los Angeles. Estimates of the film's final budget have varied. Wichard quoted it as $17 million after the mid-production reboot, but $25 million before launch. However, a Stonebridge executive reiterated at the same time that the cost-conscious production had been capped to $17 million. In August 1991, Epic Productions sued producer Yoram Ben Ami for $8 million, accusing him of being responsible for many of the film's creative and logistical woes, resulting in cost overruns that took it from a projected $7 million budget to more than $15 million. The outcome of the lawsuit was not publicized.
== Neuroscience organizations == The largest professional neuroscience organization is the Society for Neuroscience (SFN), which is based in the United States but includes many members from other countries. Since its founding in 1969 the SFN has grown steadily: as of 2010 it recorded 40,290 members from 83 countries. Annual meetings, held each year in a different American city, draw attendance from researchers, postdoctoral fellows, graduate students, and undergraduates, as well as educational institutions, funding agencies, publishers, and hundreds of businesses that supply products used in research. Other major organizations devoted to neuroscience include the International Brain Research Organization (IBRO), which holds its meetings in a country from a different part of the world each year, and the Federation of European Neuroscience Societies (FENS), which holds a meeting in a different European city every two years. FENS comprises a set of 32 national-level organizations, including the British Neuroscience Association, the German Neuroscience Society (Neurowissenschaftliche Gesellschaft), and the French Société des Neurosciences. The first National Honor Society in Neuroscience, Nu Rho Psi, was founded in 2006. Numerous youth neuroscience societies which support undergraduates, graduates and early career researchers also exist, such as Simply Neuroscience and Project Encephalon. In 2013, the BRAIN Initiative was announced in the US.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.